TCG Crossover Management, LLC
tcgcrossover.com Direct investor
TCG Crossover is an investment firm focused on innovative biotech companies, supporting private and public companies developing transformative medicines. It has offices in Palo Alto, San Francisco, and New York City, and invests globally.
TCG Crossover Management, LLC is a venture capital firm headquartered in Palo Alto, United States. It invests directly in companies, in biotech, pharmaceuticals and life sciences.
“We invest in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines.”
— TCG Crossover Management, LLC, own website
- Layer
- Direct investor
- Type
- Venture capital
- Stage
- Not stated
- Headquarters
- Palo Alto, United States
- Invests in
- North America, Europe, China
- Sectors
- biotech, pharmaceuticals, life sciences
Team, as TCG Crossover Management, LLC publishes it
- Chen Yu Managing Partner
- Cariad Chester Managing Partner
- Giuliano Marostica Managing Partner
- Dandan Dong Managing Partner
- George Feng Associate (Bioengineer)
- Bill Zhang Analyst
- Haithem Laaribi Associate
- Suan Tuang Associate
- Michael Albert Associate
- Ali Niazi Analyst
- Roger Zhang Principal
- Craig Skaling COO & CFO
Names and roles exactly as listed on tcgcrossover.com. Nothing else about these people is recorded.
Most shared portfolio companies with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 35 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.
- The Column Group 4 shared companies: plexium.com, synthekine.com, eikontx.com, carmot.us
- OrbiMed 4 shared companies: adcendo.com, candidrx.com, adarx.com, upstreambio.com
- RA Capital Management 4 shared companies: adcendo.com, aktisoncology.com, cgoncology.com, synthekine.com
- Bain Capital Life Sciences 4 shared companies: synthekine.com, adarx.com, upstreambio.com, alkeuspharma.com
- Atlas Venture 3 shared companies: affiniatx.com, obsidiantx.com, pheontx.com
- EcoR1 Capital 3 shared companies: affiniatx.com, aktisoncology.com, eikontx.com
- Vida Ventures 3 shared companies: adcendo.com, aktisoncology.com, candidrx.com
- Foresite Capital 3 shared companies: cgoncology.com, candidrx.com, eikontx.com
- Samsara BioCapital, LLC 3 shared companies: synthekine.com, upstreambio.com, rayzebio.com
- venBio Partners LLC 3 shared companies: candidrx.com, rayzebio.com, vicebio.com
and 25 more — the graph.
Where this comes from
Every fact above was read from a page TCG Crossover Management, LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://tcgcrossover.com/name, status
- https://tcgcrossover.com/about-us/is_investor, layer, type, hq_country, hq_city, invests_in_geographies, sectors, thesis_quote, thesis_quote_page, description
- https://tcgcrossover.com/our-team/people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 5212 · added 2026-09-03 · link last verified 2026-10-21 · confidence high
Similar investors
- Boutique Venture PartnersVenture capital · Pre-seed – Series A · Palo Alto, United States
- Frazier Life Sciences Management, LPVenture capital · Seed – Growth · Palo Alto, United States
- Samsara BioCapital, LLCVenture capital · Series A – Series C+ · Palo Alto, United States
- Versant VenturesVenture capital · Seed – Growth · San Francisco, United States
- 7G BioVenturesVenture capital · Burlingame, United States
- Apple Tree PartnersVenture capital · Seed – Growth · New York, United States